Sonova Holding Ag Unsponsored Adr ( (SONVY) ) has released its Q2 earnings. Here is a breakdown of the information Sonova Holding Ag Unsponsored Adr presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sonova Holding AG, a leader in hearing care solutions, operates in the healthcare sector, providing innovative products such as hearing aids and cochlear implants. In its semi-annual report for 2025/26, Sonova reported a mixed financial performance with sales reaching CHF 1,815.4 million, a 4.9% increase in local currencies but a 1.0% decline in Swiss francs due to currency headwinds. The company’s Hearing Instruments and Audiological Care businesses showed robust growth, while the Consumer Hearing and Cochlear Implants segments faced challenges. Key highlights include the launch of new products like the Phonak Infinio Ultra Sphere™, which utilizes AI for enhanced speech clarity, and the Virto R Infinio, a rechargeable custom in-the-ear device. Despite currency challenges, Sonova’s normalized EBITA rose by 16.0% in local currencies, reflecting strong operational performance. Looking ahead, Sonova remains optimistic about its growth prospects, expecting sales to increase by 5%-9% and EBITA to grow by 14%-18% for the full financial year, assuming no significant new tariffs or disruptions.